64304500CRD2001: A Phase 2b Randomized Double-blind Placebo-controlled Parallel-group Multicenter Protocol to Evaluate the Safety and Efficacy of JNJ-64304500 in Subjects with Moderately to Severely Active Crohn?s Disease
Brief description of study
The purpose of the study is to assess the safety and efficacy of JNJ-64304500 in participants with moderately to severely active Crohn's disease
Clinical Study Identifier: s16-00963
ClinicalTrials.gov Identifier: NCT02877134
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
